These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8967987

  • 1. Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding.
    Barbhaiya H, McClain R, Ijzerman A, Rivkees SA.
    Mol Pharmacol; 1996 Dec; 50(6):1635-42. PubMed ID: 8967987
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
    Baraldi PG, Romagnoli R, Pavani MG, Nuñez Mdel C, Tabrizi MA, Shryock JC, Leung E, Moorman AR, Uluoglu C, Iannotta V, Merighi S, Borea PA.
    J Med Chem; 2003 Feb 27; 46(5):794-809. PubMed ID: 12593659
    [Abstract] [Full Text] [Related]

  • 3. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
    Rivkees SA, Lasbury ME, Barbhaiya H.
    J Biol Chem; 1995 Sep 01; 270(35):20485-90. PubMed ID: 7657625
    [Abstract] [Full Text] [Related]

  • 4. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA, Miller RC, Eck M, Paquet JL.
    Mol Pharmacol; 1994 May 01; 45(5):983-90. PubMed ID: 8190113
    [Abstract] [Full Text] [Related]

  • 5. Identification of the adenine binding site of the human A1 adenosine receptor.
    Rivkees SA, Barbhaiya H, IJzerman AP.
    J Biol Chem; 1999 Feb 05; 274(6):3617-21. PubMed ID: 9920910
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain.
    Rosati AM, Traversa U.
    Biochem Pharmacol; 1999 Aug 15; 58(4):623-32. PubMed ID: 10413299
    [Abstract] [Full Text] [Related]

  • 7. Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors.
    Hill RJ, Oleynek JJ, Hoth CF, Kiron MA, Weng W, Wester RT, Tracey WR, Knight DR, Buchholz RA, Kennedy SP.
    J Pharmacol Exp Ther; 1997 Jan 15; 280(1):122-8. PubMed ID: 8996189
    [Abstract] [Full Text] [Related]

  • 8. Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis.
    Jagerschmidt A, Guillaume N, Roques BP, Noble F.
    Mol Pharmacol; 1998 May 15; 53(5):878-85. PubMed ID: 9584214
    [Abstract] [Full Text] [Related]

  • 9. Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors.
    Ivanov AA, Palyulin VA, Zefirov NS.
    J Mol Graph Model; 2007 Jan 15; 25(5):740-54. PubMed ID: 17095272
    [Abstract] [Full Text] [Related]

  • 10. Role of the second transmembrane domain of rat adenosine A1 receptor in ligand-receptor interaction.
    Xie KQ, Cao Y, Zhu XZ.
    Biochem Pharmacol; 2006 Mar 14; 71(6):865-71. PubMed ID: 16414025
    [Abstract] [Full Text] [Related]

  • 11. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O, Kieć-Kononowicz K.
    J Comput Chem; 2009 Jan 15; 30(1):14-32. PubMed ID: 18496794
    [Abstract] [Full Text] [Related]

  • 12. Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A(3) adenosine receptor.
    Palmer TM, Stiles GL.
    Mol Pharmacol; 2000 Mar 15; 57(3):539-45. PubMed ID: 10692494
    [Abstract] [Full Text] [Related]

  • 13. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
    Dalpiaz A, Townsend-Nicholson A, Beukers MW, Schofield PR, IJzerman AP.
    Biochem Pharmacol; 1998 Dec 01; 56(11):1437-45. PubMed ID: 9827575
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
    Marston HM, Finlayson K, Maemoto T, Olverman HJ, Akahane A, Sharkey J, Butcher SP.
    J Pharmacol Exp Ther; 1998 Jun 01; 285(3):1023-30. PubMed ID: 9618404
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.
    Cappellacci L, Franchetti P, Pasqualini M, Petrelli R, Vita P, Lavecchia A, Novellino E, Costa B, Martini C, Klotz KN, Grifantini M.
    J Med Chem; 2005 Mar 10; 48(5):1550-62. PubMed ID: 15743197
    [Abstract] [Full Text] [Related]

  • 16. A highly conserved tryptophan residue in the fourth transmembrane domain of the A adenosine receptor is essential for ligand binding but not receptor homodimerization.
    Suzuki T, Namba K, Yamagishi R, Kaneko H, Haga T, Nakata H.
    J Neurochem; 2009 Aug 10; 110(4):1352-62. PubMed ID: 19558453
    [Abstract] [Full Text] [Related]

  • 17. Aspartate 55 in the Na+/proline permease of Escherichia coli is essential for Na+-coupled proline uptake.
    Quick M, Jung H.
    Biochemistry; 1997 Apr 15; 36(15):4631-6. PubMed ID: 9109673
    [Abstract] [Full Text] [Related]

  • 18. The role of the second and third extracellular loops of the adenosine A1 receptor in activation and allosteric modulation.
    Peeters MC, Wisse LE, Dinaj A, Vroling B, Vriend G, Ijzerman AP.
    Biochem Pharmacol; 2012 Jul 01; 84(1):76-87. PubMed ID: 22449615
    [Abstract] [Full Text] [Related]

  • 19. Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.
    Kennedy AP, Mangum KC, Linden J, Wells JN.
    Mol Pharmacol; 1996 Oct 01; 50(4):789-98. PubMed ID: 8863823
    [Abstract] [Full Text] [Related]

  • 20. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD.
    Protein Sci; 1999 Nov 01; 8(11):2347-54. PubMed ID: 10595537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.